The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.
L-H ChangC-M HwuC-H ChuY-C LinC-C HuangJ-Y YouH-S ChenLiang-Yu LinPublished in: Journal of endocrinological investigation (2021)
Both sTNFR1 and FGF-21 levels were associated with renal outcomes of in patients with type 2 diabetes, and the combination of the abovementioned markers exhibits better predictability.